|
HS Code |
443185 |
| Chemical Name | Nandrolone |
| Common Names | 19-nortestosterone |
| Drug Class | Anabolic androgenic steroid (AAS) |
| Molecular Formula | C18H26O2 |
| Molecular Weight | 274.40 g/mol |
| Cas Number | 434-22-0 |
| Legal Status | Prescription-only in many countries |
| Administration Route | Intramuscular injection |
| Primary Use | Treatment of anemia and muscle wasting diseases |
| Half Life | Approximately 6-12 days (as Decanoate ester) |
| Origin | Synthetic derivative of testosterone |
| Bioavailability | Low oral, high intramuscular |
| Protein Binding | Approximately 50% |
| Metabolism | Hepatic |
| Elimination | Renal |
As an accredited Nandrolone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Nandrolone packaging features a white-labeled 10 mL amber glass vial, marked “Nandrolone 250 mg/mL,” with secure flip-off cap. |
| Shipping | Nandrolone is shipped in compliance with all hazardous materials regulations. It must be securely packaged in clearly labeled containers, protected from light and moisture, and accompanied by proper documentation. Transport is handled by registered carriers certified for pharmaceutical or chemical substances, ensuring safety and legal adherence throughout transit. |
| Storage | Nandrolone should be stored in a tightly closed container at room temperature, ideally between 20°C to 25°C (68°F to 77°F), away from heat, moisture, and direct light. It must be kept out of reach of children and unauthorized individuals. Avoid storing it in the bathroom or areas prone to excessive temperature fluctuations or humidity. |
Applications of Nandrolone in Industrial ManufacturingNandrolone, an anabolic steroidal raw material, finds controlled use in various pharmaceutical and veterinary production environments. Its industrial integration requires strict adherence to international compliance, specialized formulation, and advanced process controls. As a direct manufacturer, we supply high-purity grades designed for regulated downstream sectors. The following sections detail specific application scenarios with a focus on quality, precision, and traceability. 1. Pharmaceutical Bulk Active Ingredient Production (API Manufacturing)Pharmaceutical companies synthesize and formulate Nandrolone-based APIs for finished injectable or oral medications indicated mainly for anemia, osteoporosis, and cachexia under medical supervision. Bulk Nandrolone enters at the initial synthesis step, proceeding through crystallization, purification, micronization, and granulation under validated process controls in GMP-certified suites. Downstream users adjust concentration based on clinical target indications and regulatory submissions. Trace batches undergo comprehensive HPLC, IR, and GC-MS analysis to ensure compliance prior to blending, encapsulation, or sterile filling. Finished APIs are directly supplied to global market pipelines only if fully certified and accompanied by DMF registration dossiers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Veterinary Hormone Feed Premix ManufacturingVeterinary hormone feed supplement producers incorporate Nandrolone derivatives as performance-enhancing additives under disease management protocols in controlled livestock operations where legally permitted. The raw material integrates during premix blending in dedicated, cross-contamination-controlled lines with strict separation from food-producing animal products. Quantitative precision is mandatory due to carry-over and withdrawal concerns. Downstream manufacturers follow species-specific guidance for formulation, extrusion, and pelleting, using validated residue detection and traceability methods. Industrial scale manufacturing responds to local regulations, particularly regarding MRLs (Maximum Residue Limits) and veterinary prescription control. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Contract Sterile Injectable FormulationContract manufacturing organizations (CMOs) specialized in hormonal injectables rely on pharmaceutical-grade Nandrolone for sterile formulation and large-scale commercial fill-finish. The raw material is introduced at the solution compounding stage under Class 100 cleanroom environments, dissolved with designated medical oils and solvents, and subjected to sterile filtration before ampoule or vial filling. Each injection lot tracks lot-specific formulation records, container closure integrity tests, and microbial integrity validation. The process demands traceable supply and technical support, mandatory pharmacopoeia reference standards, and release testing per customer specifications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Reference Standard Production for Analytical LaboratoriesSpecialty chemical manufacturers supply certified Nandrolone reference standards for regulatory compliant laboratories conducting residue analysis, purity profiling, and doping control. The standards require ultra-high purity, lot-specific documentation, and traceability. Production involves advanced chromatography and crystallization, with batch release tied to exact mass balance, spectroscopic matching, and often certified by ISO 17034 or equivalent. Reference standards are used for assay calibration, QC testing, and regulatory method development, frequently by pharmaceutical laboratories, forensic labs, custom synthesis firms, and anti-doping authorities. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Nandrolone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Nandrolone stands out in our production halls as a compound that has earned steady demand from medical, pharmaceutical, and research applications for decades. Our experience in manufacturing this anabolic steroid dates back to the early years, when market requirements were still evolving and consistent output presented more of a challenge than it does today. Over time, we standardized our production lines to deliver high-purity nandrolone that remains free from residual solvents or process impurities. Our team spends much of its time fine-tuning each batch, as there’s little tolerance for deviation when producing a material that gets scrutinized at every turn.
Our primary model is simply Raw Nandrolone Base, Powdered Form. Most customers choose this as it easily integrates with a broad range of formulation methods. Particle size, moisture content, and specific gravity always draw questions from formulation chemists. We routinely measure and publish results from every lot—typical purity exceeds 99% by HPLC, and our water content never surpasses 0.1%. These values come from continuous monitoring in our in-house labs, not from generic specification sheets.
No matter how pristine the equipment or how detailed the standard operating procedures, actual experience counts when handling nandrolone. Production of this compound means working with sensitive intermediates and reagents that react to unexpected fluctuations in temperature or pressure. Our crews have learned over the decades that real control requires regular sampling during the entire synthesis—not just at the end. It’s not unusual to pause a run, retrace steps, and catch minor shifts before they impact the main reaction. Through these habits, we avoid introducing side products and protect the integrity of each batch.
Nandrolone’s sensitivity extends to its storage and handling. Temperature, humidity, and even residual oxygen influence product quality and shelf stability. We built our storage rooms to keep temperature between 2–8°C, monitored by digital sensors, with backup generators in case of power loss. Packaging comes in triple-sealed, light-blocking drums. Through regular audits, we confirm that each container’s environment matches what we report. These protections add cost, but they maintain the trust we have built over years with clinics and research houses that cannot afford a spoiled lot.
As a manufacturer working with similar steroids—testosterone esters, stanozolol, methenolone, and others—it’s clear how nandrolone distinguishes itself. Beyond its chemical structure, which lacks a methyl group most synthetics bear, nandrolone brings a moderate anabolic effect with noticeably less androgenic spillover. This subtlety appeals to those in clinical fields seeking tissue-building without the aggressive side reactions triggered by more potent androgens.
A common question concerns the distinction between nandrolone base and nandrolone esters, such as nandrolone decanoate and nandrolone phenylpropionate. From our vantage, the main difference involves the rate at which each is absorbed and their practicality for formulation. Nandrolone base dissolves slowly in oil, making it attractive for long-term depot preparations, but less suited for quick-release or oral applications. By contrast, esters attach to the molecule, allowing medical staff to match release profiles to patient need—a technical difference, but one with real consequences for dosing and side effect profiles.
Other compounds in our catalog sometimes overshadow nandrolone in raw anabolic strength, yet few rival its profile of mild side effects. Medical literature, and our own customer feedback, confirm that clinicians using our nandrolone batches consistently report fewer issues tied to water retention, adverse lipid profiles, or hair loss than seen with agents like trenbolone or boldenone. This tolerance gives buyers the confidence to specify it where safety draws more scrutiny than brute muscle gains.
Specifications for this product used to vary wildly in the market. At our facility, strict adherence to quality standards is clear in each certificate of analysis supplied. We rely on validated methods for chemical identity (NMR and MS for spot-checking), purity (HPLC as a routine, with GC-MS for confirming no trace-level contaminants), and assay of moisture (by Karl Fischer titration). Microbial testing happens for every batch—no batch leaves without confirmation of sterile starting status. We often welcome customer audits and provide in-person walk-throughs to verify procedures firsthand.
Another routine part of our job involves answering customer questions about particle size and flow characteristics. Some buyers have quite specific granulation needs, due to their own tablet-pressing or blending processes. We supply a standard particle size range, typically d50 of 40–60 microns, but custom milling requests come through weekly. Our process engineers configure the jet mills accordingly to bring consistency. Service on this front drives repeat business. Some customers spend weeks matching their excipients, only to settle on the base powder grade after all, due to the smoother blending it offers in low-water systems.
It’s tempting to think that one steroid could substitute directly for another, but that doesn’t fit the science nor the lived experience from formulation teams. Nandrolone’s metabolic pathway diverges significantly from, say, testosterone. Aromatase converts much less nandrolone to estrogen, and the resulting metabolite—dihydronandrolone—carries weaker androgenic properties than dihydrotestosterone (DHT) produced from testosterone. This means side effects like gynecomastia or oily skin show up less.
Some product managers ask why we don’t simply focus on newer molecules. The answer comes from doctors who order specific, well-characterized steroids for therapeutic reasons. Nandrolone demonstrates a predictable pattern of muscle growth, low liver toxicity (unlike 17-alpha alkylated agents), and a safety record that encourages its use in chronic medical management. Its long history in hospital pharmacies has built a foundation of trust, where less proven compounds might generate legal or regulatory hurdles.
We routinely compare feedback from customers on stanozolol, methenolone, and oxandrolone as well. Each one offers a separate benefit—stanozolol for less weight gain, oxandrolone for moderate anabolic strength with virtually no androgenic component. But nandrolone claims middle ground with decent anabolic effect and tolerable, manageable side effects. Customers requiring a steroid injection for muscle wasting, anemia, or osteoporosis often circle back to nandrolone after reviewing other choices, due to its reputation and clinical literature.
Most of our bulk supply goes directly to licensed pharmaceutical companies for further refinement and formulation into final medications. These teams are not looking for bare-minimum specs; they require repeatable quality, transparency in documentation, and real delivery reliability. Each shipment includes a complete lot traceability file, test results from independent third-party labs, and details of every reagent and solvent used in the process.
Buyers who have experienced issues with substandard material elsewhere—particularly imports with questionable purity—share stories about failed products, recalls, or failed patient outcomes. Such events don’t just tarnish the supply chain; they damage reputations and can bring regulatory censure. By documenting every production run and conducting both in-process and post-process analytical checks, we give the buyer and their end users confidence. Our process allows group leaders to sign off on every shipment, tying responsibility directly to the people who made the product.
We routinely audit our own sources for starting materials. With nandrolone, the precursor chemicals must meet even tighter requirements than many think. Even small traces of halogenated byproducts or oxidized intermediates spoil downstream reactions or introduce risks. We test each input before and after use—double-checking against established benchmarks that we update annually when new literature or regulatory guidance appears. Any supplier failing to meet the standards is replaced, often after in-person inspection or analysis of their production procedures.
Our company tracks how demand for pharmaceutical actives changes in response to clinical studies, new regulations, and advances in therapy. Recent years brought increased scrutiny on anabolic steroid abuse, as well as expanded interest in using agents like nandrolone for treating diseases such as cachexia or certain anemias. We engage with both regulatory authorities and independent research labs to keep pace with these developments and offer compliance support for our customers.
Some of the toughest questions come from new suppliers or importers who approach us after running into trouble with customs or product registration. Most expect nandrolone to pass through regulatory scrutiny so long as the paperwork appears correct. Real-world experience says otherwise—dossiers that lack full traceability or consistent data on impurities trigger suspicion during import checks. By taking extra time on documentation, batch-release, and shipping procedures, we cut down on shipment delays, destroyed goods, and unnecessary costs. This expertise comes from a long record of direct negotiation with customs officers and pharmacovigilance teams across markets.
A regular concern involves keeping manufacturing current with evolving guidelines on impurity testing, residual solvents, and reference standard calibration. Our laboratory teams calibrate equipment before every test run and cross-check newer reference standards with external laboratories. This hands-on attention limits the risk of outdated or erroneous data finding its way into a product specification. As regulatory authorities and pharmacopeias regularly update their advice, we participate in industry groups and respond promptly to guidance changes, sometimes rewriting protocols or validating new analytical methods before the next production campaign.
Manufacturing nandrolone, with its rigorous controls, does not reward shortcuts. The market punishes any attempt to game the system. We have spent years developing not just the chemical process but a culture of diligence—constant training, equipment audits, and site inspections form part of the weekly rhythm. More recently, we implemented digital batch records and QR-based tracking, enabling buyers to review a product's entire journey from raw input to finished material. These steps reinforce the claims we make in data sheets and help maintain trust with ever-vigilant regulatory agencies.
Some competitors cut costs on process controls, lax cleaning between batches, or weak documentation. The results speak for themselves: off-standard colors, inconsistent melting points, batch recalls, or investigation requests from authorities. Our operation, by contrast, takes the long view. Investments in proper contamination controls, analytical labs, and staff training are not just optional; they secure business stability and protect the people down the line who rely on accurate medication dosing.
Nandrolone continues to prove itself as an anchor compound in our production portfolio. We watch as downstream partners use it as a base for sterile depot injections, oral blends, and even veterinary preparations for muscle-wasting conditions. Every project, whether clinical trial or commercial product, relies on consistent input quality. By sharing our lessons learned and the practical challenges of this chemistry, we invite customer questions, on-site visits, and process audits. These conversations reveal ongoing needs for improved purity, refined particle control, or custom documentation that adapts as clinical requirements change.
Every year sees new techniques for waste reduction, yield optimization, and energy savings. We incorporate best practices wherever feasible—energy recovery in our synthesis steps, closed-loop water recycling, and reduced reliance on hazardous solvents. These priorities reflect the demands of regulators, customers, and our own sense of stewardship. We publish annual sustainability data, tracking waste streams and carbon intensity, because our buyers increasingly want not just a product but assurance that its manufacture aligns with their environmental responsibilities.
Customers sometimes underestimate the support a manufacturer like us can provide. Advising on formulation challenges, troubleshooting analytical anomalies, or even recommending the most stable excipient systems for depot injections—these tasks shape daily life for our senior technical staff. We maintain an open-door policy for audits and site visits, recognizing that transparency stands as the strongest assurance of reliability. By sharing stability study data and early reports of regulatory developments, we help customers plan production schedules, anticipate shipment timing, and meet inspection requirements.
Onsite training for bulk buyers has become a growing service. Teams visit our site to observe critical synthesis steps, understand the logic behind every control point, and discuss potential modifications for unique application needs. These interactions benefit both sides: clients pick up manufacturing insights, while our engineers gain a clearer picture of the real-world use cases that shape demand.
Despite steady system improvements, challenges persist in the broader market. Sourcing high-purity intermediates and keeping transport routes open during geopolitical disruptions remain daily concerns. Prices of critical reagents can fluctuate, and regulatory changes often arrive with little lead time. Our long-term relationships with trusted suppliers soften the impact when sudden shortages arise; in some cases, we hold strategic stocks of precursors to bridge demand spikes or outages. Business continuity planning forms part of our annual strategy review, along with scenario drills for recall management and rapid-response containment.
Another persistent challenge lies in maintaining up-to-date compliance with pharmacopoeial changes. As new impurity limits are published, or as authorities introduce additional documentation requirements, we step up training for operators and quality control analysts. Sometimes this means revalidating methods on short notice, running side-by-side analyses with certified reference labs, and updating customer-facing documentation before deadline. Sound investments in analytical infrastructure—state-of-the-art chromatography, mass spectrometry, and information management systems—enables this adaptability.
Modern nandrolone production draws on both tradition and technology. We retain experienced chemists familiar with older synthesis routes and supplement their insight with automation, continuous monitoring, and data analytics. Remote monitoring via SCADA systems enables offsite technicians to diagnose and address anomalies within minutes, reducing downtime and inefficiency.
We expect product demand to shift over the coming years as new clinical trials clarify additional uses for nandrolone, or as regulatory bodies revise treatment guidelines. Rather than wait for sweeping changes, our specialty teams review each change in real-time, updating specs and documentation daily. Our engagement with external partners—API partners, regulatory consultants, academic labs—lets us anticipate shifts and respond proactively.
Nandrolone’s place in our product range grew from years of hard work, adaptation, and honest engagement with the realities of bulk pharmaceutical manufacturing. Decisions about process optimization, documentation, or support services stem from results seen in our own factories and customer experiences. No shortcut or simple substitution satisfies the unique needs met by this compound. On the floor, in labs, and through customer relationships, nandrolone remains a bellwether—trusted where results matter, and proven by the repeat orders from those whose livelihoods depend on steady, transparent supply.